BALTIMORE, Md. — Lupin announced on Tuesday that it has received approval from the United States Food and Drug Administration (FDA) to market a generic version of Alvogen’s Fluoxetine Tablets, 60mg.
Fluoxetine is indicated in the treatment of major depressive disorders.

Fluoxetine Tablets, 60mg, had annual sales of approximately $42.5m in the U.S.